Detalhe da pesquisa
1.
In Vitro Activity of WCK 5222 (Cefepime-Zidebactam) against Worldwide Collected Gram-Negative Bacilli Not Susceptible to Carbapenems.
Antimicrob Agents Chemother
; 64(12)2020 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32928739
2.
In Vitro Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Latin American Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015.
Antimicrob Agents Chemother
; 63(4)2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30670424
3.
In Vitro Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Asia-Pacific Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015.
Antimicrob Agents Chemother
; 62(7)2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29760124
4.
In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program.
Antimicrob Agents Chemother
; 60(1): 343-7, 2016 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26503659
5.
Multiyear, Multinational Survey of the Incidence and Global Distribution of Metallo-ß-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa.
Antimicrob Agents Chemother
; 60(2): 1067-78, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26643349
6.
Global Dissemination of blaKPC into Bacterial Species beyond Klebsiella pneumoniae and In Vitro Susceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam.
Antimicrob Agents Chemother
; 60(8): 4490-500, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27161636
7.
Assessment of the In Vitro Activity of Ceftazidime-Avibactam against Multidrug-Resistant Klebsiella spp. Collected in the INFORM Global Surveillance Study, 2012 to 2014.
Antimicrob Agents Chemother
; 60(8): 4677-83, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27216054
8.
In vitro activity of ceftaroline against bacterial pathogens isolated from skin and soft tissue infections in Europe, Russia and Turkey in 2012: results from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance programme.
J Antimicrob Chemother
; 71(1): 162-9, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26503667
9.
In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria.
J Antimicrob Chemother
; 71(3): 670-7, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26645269
10.
In vitro activity of aztreonam-avibactam against a global collection of Gram-negative pathogens from 2012 and 2013.
Antimicrob Agents Chemother
; 59(7): 4239-48, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25963984
11.
In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolates Collected in 2012 from Latin American Countries as Part of the AWARE Surveillance Program.
Antimicrob Agents Chemother
; 59(12): 7873-7, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26416860
12.
Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013.
Antimicrob Agents Chemother
; 59(6): 3606-10, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25801558
13.
Global in vitro activity of tigecycline and comparator agents: Tigecycline Evaluation and Surveillance Trial 2004-2013.
Ann Clin Microbiol Antimicrob
; 14: 27, 2015 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25958201
14.
Antimicrobial susceptibility testing of clinical isolates of Gram-negative bacilli collected in Morocco by the ATLAS Global Surveillance Program from 2018 to 2020.
J Glob Antimicrob Resist
; 30: 23-30, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35447385
15.
Carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa causing infection in Africa and the Middle East: a surveillance study from the ATLAS programme (2018-20).
JAC Antimicrob Resist
; 4(3): dlac060, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35733913
16.
Susceptibility of Klebsiella pneumoniae isolates from intra-abdominal infections and molecular characterization of ertapenem-resistant isolates.
Antimicrob Agents Chemother
; 55(8): 3917-21, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21670192
17.
In vitro activity of ceftazidime/avibactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa from Middle Eastern and African countries: ATLAS global surveillance programme 2015-18.
JAC Antimicrob Resist
; 3(2): dlab067, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34223129
18.
Susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in the United States, 2007-2008: results of the Study for Monitoring Antimicrobial Resistance Trends (SMART).
Antimicrob Agents Chemother
; 54(7): 3031-4, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20457818
19.
Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrobial Resistance Trends (SMART).
Antimicrob Agents Chemother
; 54(7): 3043-6, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20421398
20.
Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007.
Antimicrob Agents Chemother
; 53(8): 3280-4, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19506060